Upstream Bio, Inc.
UPB
$17.63
-$0.11-0.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.56% | -28.38% | -32.83% | -8.95% | -34.73% |
| Total Depreciation and Amortization | -2.33% | -12.24% | 250.00% | 7.69% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 69.25% | -64.33% | 123.17% | 344.86% | 110.36% |
| Change in Net Operating Assets | 92.89% | -1,035.96% | -283.82% | -88.69% | 264.04% |
| Cash from Operations | 4.68% | -109.90% | -40.47% | -73.74% | 54.24% |
| Capital Expenditure | -- | -- | 43.25% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 106.01% | -606.93% | 2,326.11% | 101.49% | -942.15% |
| Cash from Investing | 105.99% | -609.17% | 2,874.31% | 101.21% | -942.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 1,435,431.58% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 98.44% | -31.20% | -1,148.12% | -- |
| Cash from Financing | 1,900.00% | -100.01% | 16,592.87% | -101.17% | 1,396.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 89.84% | -186.90% | 2,163.86% | -189.69% | 178.77% |